Fred Alger Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-407,170
| Closed | -$41.5M | – | 559 |
|
|
2023
Q2 | $41.5M | Buy |
407,170
+232,469
| +133% | +$23.7M | 0.21% | 112 |
|
|
2023
Q1 | $15.9M | Sell |
174,701
-1,334,703
| -88% | -$121M | 0.09% | 170 |
|
|
2022
Q4 | $57.3M | Buy |
1,509,404
+897,481
| +147% | +$34.1M | 0.31% | 96 |
|
|
2022
Q3 | $15.4M | Buy |
+611,923
| New | +$15.4M | 0.08% | 181 |
|
|
2021
Q1 | – | Sell |
-8,028
| Closed | -$992K | – | 520 |
|
|
2020
Q4 | $992K | Sell |
8,028
-181
| -2% | -$22.4K | ﹤0.01% | 370 |
|
|
2020
Q3 | $800K | Sell |
8,209
-8,375
| -51% | -$816K | ﹤0.01% | 360 |
|
|
2020
Q2 | $2.59M | Buy |
16,584
+2,842
| +21% | +$443K | 0.01% | 293 |
|
|
2020
Q1 | $1.98M | Buy |
13,742
+5,242
| +62% | +$757K | 0.01% | 273 |
|
|
2019
Q4 | $1.74M | Buy |
8,500
+5,500
| +183% | +$1.12M | 0.01% | 298 |
|
|
2019
Q3 | $241K | Buy |
+3,000
| New | +$241K | ﹤0.01% | 401 |
|
|
2019
Q1 | – | Sell |
-3,000
| Closed | -$168K | – | 577 |
|
|
2018
Q4 | $168K | Buy |
+3,000
| New | +$168K | ﹤0.01% | 381 |
|